CEPI, the Coalition for Epidemic Preparedness Innovations, yesterday announced a $43.5 million deal with pharmaceutical giant AstraZeneca to advance the development of a novel antibody that could ...
More information: Bo Shi et al, Heavy-chain antibody targeting of CD38 NAD+ hydrolase ectoenzyme to prevent fibrosis in ...
The antibody molecule in particular has been ... the reassembly of naturally occurring genes encoding the heavy- and light-chain domains from either immune 1,2 or nonimmune B-cell sources 3 ...
“Building on Novimmune’s long experience in antibody discovery and development ... a production cell expresses a single heavy chain, alongside κ and λ light chains, which self-assemble ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback